98
Participants
Start Date
February 29, 2004
Primary Completion Date
May 31, 2007
Study Completion Date
May 31, 2007
PI-88
PI-88+docetaxel
docetaxel
docetaxel only
Institute of Oncology at Prince of Wales Hospital, Randwick
Sydney Cancer Centre at Royal Prince Alfred Hospital, Sydney
Royal North Shore Hospital, St Leonards
Sydney Heamatology and Oncology Clinics, Hornsby
Newcastle Mater Misericordiae Hospital, Waratah
Alfred Hospital, Melbourne
Murray Valley Private Hospital and Cancer Treatment Centre, Wodonga
Prince Charles Hospital, Chermside
Mater Medical Centre, South Brisbane
Princess Alexandra Hospital, Brisbane
Nambour General Hospital, Nambour
Queen Elizabeth Hospital, Woodville
Sir Charles Gairdner Hospital - Perth, Perth
Lead Sponsor
Collaborators (1)
Medigen Biotechnology Corporation
INDUSTRY
Cellxpert Biotechnology Corp.
INDUSTRY